USPTO serial 79333099
SERCA PHARMACEUTICALS
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- Nov 14, 2023
- Examiner
- SEVERSON, JUSTIN
- Law office
- PUBLICATION AND ISSUE SECTION
What this means
Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.
Need help with SERCA PHARMACEUTICALS?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Susan Stabe
Susan Stabe Kutak Rock LLP2405 Grand Boulevard, Suite 600Kansas City, MO 64108United StatesGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 005 | pharmaceutical preparations for treatment of cardiovascular diseases; pharmaceutical preparations for treatment of myocardial infarction; pharmaceutical preparations for prophylactic treatment of cardiovascular diseases; pharmaceutical preparations for prophylactic treatment of myocardial infarction; cardiovascular disease prophylactic preparations for preventing cardiovascular disease; myocardial infarction prophylactic preparations for preventing myocardial infarction | ACTIVE | — |
| 035 | Promoting of pharmaceutical products; retail stores services featuring pharmaceutical products; promoting of pharmaceutical products for therapeutic treatment of cardiovascular diseases, products for therapeutic treatment of myocardial infarction, products for prophylactic treatment of cardiovascular diseases and products for prophylactic treatment of myocardial infarction; retail store services featuring pharmaceutical products for therapeutic treatment of cardiovascular diseases, products for therapeutic treatment of myocardial infarction, products for prophylactic treatment of cardiovascular diseases and products for prophylactic treatment of myocardial infarction; promoting of cardiovascular disease prophylactic preparations and myocardial infarction prophylactic preparation; retail store services featuring cardiovascular disease prophylactic preparations and myocardial infarction prophylactic preparation | ACTIVE | — |
| 040 | Treatment of materials for use in production of pharmaceuticals; production and custom manufacturing of pharmaceuticals; production and custom manufacturing of preparations for treatment of cardiovascular diseases, preparations for treatment of myocardial infarction, preparations for prophylactic treatment of cardiovascular diseases and preparations for prophylactic treatment of myocardial infarction; production and custom manufacturing of cardiovascular disease prophylactic preparations and myocardial infarction prophylactic preparations | ACTIVE | — |
| 042 | Research and development of pharmaceutical preparations for treatment of cardiovascular diseases, preparations for therapeutic treatment of myocardial infarction, preparations for prophylactic treatment of cardiovascular diseases and preparations for prophylactic treatment of myocardial infarction; research and development of cardiovascular disease prophylactic preparations and myocardial infarction prophylactic preparations | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by SERCA PHARMACEUTICALS AS
- Other trademarks owned by SERCA PHARMACEUTICALS AS
- Other trademarks owned by SERCA PHARMACEUTICALS AS
- Other trademarks in Class 005
- Other trademarks in Class 035
- Other trademarks in Class 040
- Other trademarks in Class 042
- Similar marks named SERCA PHARMACEUTICALS
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Jul 17, 2025 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| Jul 17, 2025 | ECDR | TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS | — |
| Jul 17, 2025 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Jul 17, 2025 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| Feb 14, 2025 | NREP | NEW REPRESENTATIVE AT IB RECEIVED | — |
| Jan 24, 2025 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| Jan 24, 2025 | ECDR | TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS | — |
| Jan 24, 2025 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Jan 24, 2025 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| Nov 8, 2024 | NREP | NEW REPRESENTATIVE AT IB RECEIVED | — |
| Mar 4, 2024 | FINO | FINAL DECISION TRANSACTION PROCESSED BY IB | — |
| Feb 14, 2024 | FICS | FINAL DISPOSITION NOTICE SENT TO IB | — |
| Feb 14, 2024 | FIMP | FINAL DISPOSITION PROCESSED | — |
| Feb 14, 2024 | FICR | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | — |
| Nov 14, 2023 | NRCC | NOTICE OF REGISTRATION CONFIRMATION EMAILED | — |
| Nov 14, 2023 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Aug 29, 2023 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Aug 29, 2023 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Aug 28, 2023 | GPNX | NOTIFICATION PROCESSED BY IB | — |
| Aug 9, 2023 | OPNS | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | — |
| Aug 9, 2023 | OP2R | NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB | — |
| Aug 9, 2023 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Jul 27, 2023 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Jul 6, 2023 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Jul 6, 2023 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Jul 6, 2023 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Apr 13, 2023 | GPRN | NOTIFICATION OF PRIORITY ACTION E-MAILED | A priority action is a type of Office Action the USPTO treats as time-sensitive. It usually means the examining attorney needs a specific response or amendment quickly — often relating to a foreign priority claim or a formal requirement. Respond within the stated deadline. |
| Apr 13, 2023 | GPRA | PRIORITY ACTION E-MAILED | A priority action is a type of Office Action the USPTO treats as time-sensitive. It usually means the examining attorney needs a specific response or amendment quickly — often relating to a foreign priority claim or a formal requirement. Respond within the stated deadline. |
| Apr 13, 2023 | CPRA | PRIORITY ACTION WRITTEN | A priority action is a type of Office Action the USPTO treats as time-sensitive. It usually means the examining attorney needs a specific response or amendment quickly — often relating to a foreign priority claim or a formal requirement. Respond within the stated deadline. |
| Mar 15, 2023 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Mar 15, 2023 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Mar 15, 2023 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Dec 28, 2022 | RFNT | REFUSAL PROCESSED BY IB | — |
| Dec 7, 2022 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Dec 7, 2022 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Nov 17, 2022 | ATRV | ATTORNEY REVIEW COMPLETED | — |
| Oct 26, 2022 | CREV | CORRECTION FROM IB ENTERED - ATTORNEY REVIEW REQUIRED | — |
| Oct 7, 2022 | ADCH | CHANGE OF NAME/ADDRESS REC'D FROM IB | — |
| Sep 27, 2022 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Sep 26, 2022 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Sep 26, 2022 | DOCK | ASSIGNED TO EXAMINER | — |
| Jul 23, 2022 | CRCV | CORRECTION TRANSACTION RECEIVED FROM IB | — |
| May 28, 2022 | NREP | NEW REPRESENTATIVE AT IB RECEIVED | — |
| Feb 19, 2022 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Feb 15, 2022 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Feb 10, 2022 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |